Global Gelfoam Market Growth 2025-2031

Global Gelfoam Market Growth 2025-2031

The global Gelfoam market size is predicted to grow from US$ 980 million in 2025 to US$ 1296 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

In order to prevent hemorrhage during surgical procedures, a wide range of hemostatic agents have been developed. And in our report, we study the hemostasis and tissue sealing agents made of gelatin matrix thrombin.

The classification of Gelfoam includes sponge and powder, and the proportion of sponge is about 65%.

Gelfoam is widely used for minimally invasive surgery, general surgery and other field. The most proportion of Gelfoam is used for general surgery, and the proportion is about 44%.

North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.

Market competition is not intense. Johnson & Johnson, Gelita, Pfizer, Baxter, Ferrosan Medical Devices, B Braun and Equimedical, etc. are the leaders of the industry, with about 92% market shares.

LP Information, Inc. (LPI) ' newest research report, the “Gelfoam Industry Forecast” looks at past sales and reviews total world Gelfoam sales in 2024, providing a comprehensive analysis by region and market sector of projected Gelfoam sales for 2025 through 2031. With Gelfoam sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gelfoam industry.

This Insight Report provides a comprehensive analysis of the global Gelfoam landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gelfoam portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gelfoam market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gelfoam and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gelfoam.

This report presents a comprehensive overview, market shares, and growth opportunities of Gelfoam market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Sponge
Powder

Segmentation by Application:
Minimally Invasive Surgery
General Surgery
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Gelita
Pfizer
Baxter
Ferrosan Medical Devices
B Braun
Equimedical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gelfoam market?

What factors are driving Gelfoam market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gelfoam market opportunities vary by end market size?

How does Gelfoam break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.